{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:35:21Z","timestamp":1725694521619},"publisher-location":"Vienna","reference-count":32,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211820346"},{"type":"electronic","value":"9783709189542"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/978-3-7091-8954-2_1","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T16:55:41Z","timestamp":1343494541000},"page":"3-10","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenetic studies of motor fluctuations in Parkinson\u2019s disease"],"prefix":"10.1007","author":[{"given":"T. N.","family":"Chase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Mouradian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Juncos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1_CR1","first-page":"347","volume":"5","author":"A Barbeau","year":"1974","unstructured":"Barbeau A (1974) The clinical physiology of side effects in long-term L-dopa therapy. Adv Neurol 5: 347\u2013365","journal-title":"Adv Neurol"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415\u2013455","journal-title":"J Neurol Sci"},{"key":"1_CR3","first-page":"560","volume":"185","author":"BS Bunney","year":"1973","unstructured":"Bunney BS, Walters JR, Roth RH, Aghajanian G (1973) Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185: 560\u2013571","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR4","first-page":"123","volume-title":"Biopharmaceutics and drug interactions","author":"DE Cadwallader","year":"1983","unstructured":"Cadwallader DE (1983) Biopharmaceutics and drug interactions. Raven Press, New York, pp 123\u2013133"},{"key":"1_CR5","first-page":"477","volume":"45","author":"TN Chase","year":"1986","unstructured":"Chase TN, Juncos J, Serrati C, Fabbrini G, Bruno G (1986) Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations. Adv Neurol 45: 477\u2013480","journal-title":"Adv Neurol"},{"key":"1_CR6","first-page":"163","volume-title":"Parkinsons disease","author":"TN Chase","year":"1987","unstructured":"Chase TN, Juncos JL, Fabbrini G, Mouradian MM (1987) Controlled release levodopa- carbidopa preparations in the treatment of motor response fluctuations in Parkinson\u2019s disease. In: Clifford-Rose F (ed) Parkinson\u2019s disease. J Libby, London, pp 163\u2013167"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1471-4159.1980.tb09969.x","volume":"34","author":"HJ Doller","year":"1980","unstructured":"Doller HJ, Connor JD (1980) Changes in neostriatal dopamine concentrations in response to levodopa infusion. J Neurochem 34: 1264\u20131269","journal-title":"J Neurochem"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/WNL.37.5.856","volume":"37","author":"G Fabbrini","year":"1987","unstructured":"Fabbrini G, Juncos JL, Mouradian MM, Serrati C, Chase TN (1987 a) 3-0-methyldopa and motor fluctuations in Parkinson\u2019s disease. Neurology 37: 856\u2013859","journal-title":"Neurology"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410210409","volume":"21","author":"G Fabbrini","year":"1987","unstructured":"Fabbrini G, Juncos JL, Mouradian MM, Serrati C, Chase TN (1987 b) Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson\u2019s disease. Ann Neurol 21: 370\u2013376","journal-title":"Ann Neurol"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1212\/WNL.24.5.431","volume":"24","author":"S Fahn","year":"1980","unstructured":"Fahn S (1980) On-off\u2019 phenomenon with levodopa therapy in parkinsonism. Neurology 24: 431\u2013441","journal-title":"Neurology"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.33.3.278","volume":"33","author":"JJ Gervas","year":"1983","unstructured":"Gervas JJ, Murdas V, Bazan E, Aguado EG, de Yebenes JG (1983) Effects of 3-OM-dopa on monoamine metabolism in rat brain. Neurology 33: 278\u2013282","journal-title":"Neurology"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/brain\/107.2.487","volume":"107","author":"RJ Hardie","year":"1984","unstructured":"Hardie RJ, Lees AJ, Stern GM (1984) On-off fluctuations in Parkinson\u2019s disease: a clinical and neuropharmacological study. Brain 107: 487\u2013506","journal-title":"Brain"},{"key":"1_CR13","first-page":"275","volume":"24","author":"O Hornykiewicz","year":"1979","unstructured":"Hornykiewicz O (1979) Compensatory biochemical changes at the striatal dopamine synapse in Parkinson\u2019s disease - limitations of L-dopa therapy. Adv Neurol 24: 275\u2013281","journal-title":"Adv Neurol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0140-6736(85)92754-0","volume":"2","author":"JL Juncos","year":"1985","unstructured":"Juncos JL, Serrati C, Fabbrini G, Chase TN (1985) Fluctuating levodopa concentrations and Parkinson\u2019s disease. Lancet 2: 440","journal-title":"Lancet"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/jnnp.50.2.194","volume":"50","author":"JL Juncos","year":"1987","unstructured":"Juncos JL, Fabbrini G, Mouradian MM, Serrati C, Kask AM, Chase TN (1987 a) Controlled release levodopa treatment of motor fluctuations in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 50: 194\u2013198","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/archneur.1987.00520220009006","volume":"44","author":"JL Juncos","year":"1987","unstructured":"Juncos JL, Fabbrini G, Mouradian MM, Serrati C, Chase TN (1987 b) Dietary influences on the antiparkinsonian response to levodopa. Arch Neurol 44: 1003\u20131005","journal-title":"Arch Neurol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1212\/WNL.37.7.1242","volume":"37","author":"JL Juncos","year":"1987","unstructured":"Juncos JL, Mouradian MM, Fabbrini G, Serrati C, Chase TN (1987 c) Levodopa methyl ester treatment of Parkinson\u2019s disease. Neurology 37: 1242\u20131245","journal-title":"Neurology"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1212\/WNL.26.6.508","volume":"26","author":"R Kartzinel","year":"1976","unstructured":"Kartzinel R, Calne DB (1976) Studies with bromocriptine Part 1. On-off\u2019 phenomena. Neurology 26: 508\u2013510","journal-title":"Neurology"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/273059a0","volume":"273","author":"T Lee","year":"1978","unstructured":"Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O (1978) Receptor basis for dopaminergic supersensitivity in Parkinson\u2019s disease. Nature 273: 59\u201361","journal-title":"Nature"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/ana.410080603","volume":"8","author":"E Melamed","year":"1980","unstructured":"Melamed E, Hefti F, Wurtman RJ (1980) Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol 8: 558\u2013563","journal-title":"Ann Neurol"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","volume":"1","author":"CD Marsden","year":"1976","unstructured":"Marsden CD, Parkes JD (1976) On-off\u2019 effects in patients with Parkinson\u2019s disease on chronic levodopa therapy. Lancet 1: 292\u2013296","journal-title":"Lancet"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archneur.1971.00490010049007","volume":"25","author":"JP Morgan","year":"1971","unstructured":"Morgan JP, Bianchine JR, Spiegel HE, Rivera-Calimlin L, Hersey RM (1971) Metabolism of levodopa in patients with Parkinson\u2019s disease. Arch Neurol 25: 39\u201344","journal-title":"Arch Neurol"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410220406","volume":"22","author":"MM Mouradian","year":"1987","unstructured":"Mouradian MM, Juncos JL, Fabbrini G, Chase TN (1987) Motor fluctuations in Parkinson\u2019s disease: pathogenetic studies and parenteral levodopa therapy. Ann Neurol 22: 415\u2013419","journal-title":"Ann Neurol"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1056\/NEJM198402233100802","volume":"310","author":"JG Nutt","year":"1984","unstructured":"Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL (1984) The \u201con-off\u201d phenomenon in Parkinson\u2019s disease. Relation to the levodopa absorption and transport. N Engl J Med 310: 483\u2013488","journal-title":"N Engl J Med"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ana.410180505","volume":"18","author":"JG Nutt","year":"1985","unstructured":"Nutt JG, Woodward WR, Anderson JL (1985) The effect of carbidopa on the pharmacokinetics of intravenous administered levodopa: The mechanism of action in the treatment of parkinsonism. Ann Neurol 18: 537\u2013543","journal-title":"Ann Neurol"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0022-510X(84)90003-0","volume":"66","author":"S Ogasahara","year":"1984","unstructured":"Ogasahara S, Nishikawa Y, Yakahashi M, Wade K, Nakamura Y, Yorifuji S, Tarui S (1984) Dopamine metabolism in the central nervous system after discontinuation of L- dopa therapy in patients with Parkinson disease. J Neurol Sci 66: 151\u2013163","journal-title":"J Neurol Sci"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1212\/WNL.29.2.194","volume":"29","author":"PS Papavasiliou","year":"1979","unstructured":"Papavasiliou PS, McDowell FH, Wang YY, Rosal U, Miller ST (1979) Plasma dopa and growth hormone in parkinsonism: oscillations in symptoms. Neurology 29: 194\u2013200","journal-title":"Neurology"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.410120310","volume":"12","author":"A Reches","year":"1982","unstructured":"Reches A, Fahn S (1982) 3-0-methyldopa blocks dopa metabolism in rat corpus striatum. Ann Neurol 12: 267\u2013271","journal-title":"Ann Neurol"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0022-510X(80)90063-5","volume":"46","author":"MN Rossor","year":"1980","unstructured":"Rossor MN, Watkins J, Brown MJ, Reid JL, Dollery CT (1980) Plasma levodopa, dopamine and therapeutic response following levodopa therapy of parkinsonian patients. J Neurol Sci 46: 385\u2013392","journal-title":"J Neurol Sci"},{"key":"1_CR30","first-page":"283","volume":"49","author":"KM Shaw","year":"1980","unstructured":"Shaw KM, Lees AJ, Stern GM (1980) The impact of treatment with levodopa in Parkinson\u2019s disease. Q J Med 49: 283\u2013293","journal-title":"Q J Med"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/WNL.25.12.1144","volume":"25","author":"I Shoulson","year":"1975","unstructured":"Shoulson I, Glaubiger GA, Chase TN (1975) On-off response: clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 25: 1144\u20131148","journal-title":"Neurology"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.25.2.177","volume":"25","author":"ES Tolosa","year":"1975","unstructured":"Tolosa ES, Martin WE, Cohen HP, Jacobson RL (1975) Patterns of clinical response and plasma dopa levels in Parkinson\u2019s disease. Neurology 25: 177\u2013183","journal-title":"Neurology"}],"container-title":["Continuous Dopaminergic Stimulation in Parkinson\u2019s Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-8954-2_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T05:10:10Z","timestamp":1606108210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-8954-2_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"ISBN":["9783211820346","9783709189542"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-8954-2_1","relation":{},"subject":[],"published":{"date-parts":[[1988]]}}}